Senator Chuck Schumer has demanded a federal probe into the flood of illicit vapes, as new state-level bans took effect on October 1. According to data cited by Senator Schumer, about 97% of disposable e-cigarette sales in the United States come from unauthorized products, and 70% of all e-cigarette sales are unauthorized.
The Demand
Schumer is calling on the FDA to investigate how unauthorized vapes keep reaching store shelves despite years of enforcement promises. The numbers behind his demand are stark. If the data he cited is accurate, nearly the entire disposable vape market in the US operates outside federal authorization, while only a small fraction of products have ever cleared the FDA’s review process.
The criticism is that the FDA has allowed the situation to drift. Only a few dozen products appear on the FDA authorized vapes list, yet thousands of unauthorized disposables remain widely available in gas stations and convenience stores across the country.
Three States, Three New Rules
October 1 brought fresh state action on three fronts. Alabama’s SB 9 now bans vaping in all public indoor spaces, including restaurants, airports, libraries, and hospitals. Virginia has implemented new tobacco retailer registration requirements, tightening who can legally sell. And Pennsylvania begins ENDS directory enforcement on October 19, with products not on the approved list subject to seizure.
These state moves follow the pattern set by earlier crackdowns. Texas has already drawn its own hard line against unauthorized disposables, which we covered in our guide to what is actually legal in Texas in 2026. The difference now is scale: multiple states are moving at once, and federal pressure is building on top.
Why It Matters
For vapers, the era of easy access to any disposable on the shelf is narrowing. Between state bans, directory laws, and a potential federal probe, the unauthorized products that dominate the market face pressure from every direction. For the industry, Schumer’s demand signals that Washington’s patience is running out, and the FDA may soon be forced to either speed up authorizations or step up seizures.
Source: WindBar